临床外科杂志 ›› 2022, Vol. 30 ›› Issue (1): 78-81.doi: 10.3969/j.issn.1005-6483.2022.01.023

• 论著 • 上一篇    下一篇

不同肾盂漏斗部夹角肾下盏结石病人采用不同术式的疗效及疗效相关因素分析

  

  1. 710032 西安,空军军医大学第一附属医院泌尿外科
  • 出版日期:2022-01-20 发布日期:2022-01-20
  • 通讯作者: 刘莹,Email:liuying8766@163.com

Analysis of curative effect and curative effect-related factors of different surgical procedures for patients with inferior calyx calculi with different funnel angles of the renal pelvis

  1. Department of Urology Surgery,the First Affiliated Hospital of Air Force Military Medical University,Shanxi,Xi’an 710032, China
  • Online:2022-01-20 Published:2022-01-20

摘要: 目的  探讨不同肾盂漏斗部夹角(IPA)肾下盏结石病人采用不同术式的疗效及疗效相关因素。
方法  2019年6月~2020年6月我院泌尿外科收治的肾下盏结石病人198例,根据IPA角度分为两组,A组IPA>30°,B组 IPA≤30°。再根据各组手术方式分为4个亚组,A1组70例,采用微通道经皮肾镜碎石术(MPCNL),A2组62例,采用输尿管软镜钬激光碎石术(FURS),B1组23例,采用FURS术,B2组43例,采用FURS联合MPCNL术。比较各组临床疗效、并发症发生情况,并分析肾下盏结石疗效的影响因素。
结果  A1组和A2组手术时间、术后住院时间、结石清除率、并发症发生率比较,差异均无统计学意义(P>0.05);B1组和B2组手术时间、术后住院时间、并发症发生率比较,差异无统计学意义(P>0.05),但B2组结石清除率高于B1组,差异有统计学意义(P<0.05)。198例病人中结石清除完全者167例(清除组),清除不完全者31例(未清除组)。清除组体质量指数(BMI)<25kg/m2者高于未清除组,清除组IPA大于未清除组,肾盂漏斗部长度(IL)、结石直径小于未清除组,差异均有统计学意义(P<0.05)。多因素Logistic 回归显示,BMI高、IPA小、IL长、结石直径大是导致肾下盏结石术后疗效不佳的独立危险因素(P<0.05)。
结论  IPA>30°的肾下盏结石,采用MPCNL和FURS的结石清除效果差别不大,但IPA≤30°的肾下盏结石,FURS结石清除效果有限,与MPCNL联合应用能获得更好的治疗效果;BMI高、IPA小、IL长、结石直径大是导致肾下盏结石术后疗效不佳的独立危险因素。

关键词: 肾盂漏斗部夹角, 肾下盏结石, 疗效, 相关因素

Abstract: Objective  To explore the curative effect of different surgical methods and analysis of curative effect-related factors in patients with inferior calyx stones with different infundibulum angles of the renal pelvis.
Methods  A retrospective analysis of the case data of 198 patients with inferior calyx stones admitted to the Department of Urology in our hospital from June 2019 to June 2020 was divided into two groups according to the IPA angle.Group A IPA>30°,Group B IPA≤30 ° group,divided into 4 subgroups according to the operation method of each group,A1 group(70 cases) was treated with microchannel percutaneous nephrolithotomy(MPCNL),and A2 group(62 cases) was treated with ureteroscopy holmium laser Lithotripsy(FURS) was used for treatment.Group B1(23 cases) was treated with FURS,and group B2(43 cases) was treated with FURS combined with MPCNL.The curative effect and complications of each group were compared,and the factors affecting the curative effect of lower calyx stones were analyzed.
Results  There was no statistically significant difference in operation time,postoperative hospital stay,stone removal rate,and complication rate between group A1 and group A2(P>0.05);group B1 and group B2 had no significant difference in operation time,postoperative hospital stay,There was no statistically significant difference in the incidence of complications(P>0.05),but the stone clearance rate in group B2 was higher than that in group B1,and the difference was statistically significant(P<0.05).Among the 198 patients,167 had complete stone removal(the removal group),and 31 cases had incomplete stone removal(uncleared group).The body mass index(BMI) <25 kg/m2 of the cleared group was higher than that of the uncleared group,the angle of the renal pelvic funnel(IPA) was higher in the cleared group,and the length of the renal pelvic funnel(IL) and stone diameter were lower than those of the uncleared group.The differences were statistically significant(P<0.05).Multivariate logistic regression showed that high BMI,small IPA,long IL,and large calculus diameter were independent risk factors that led to poor postoperative efficacy of inferior calyx stones(P<0.05).
Conclusion  In the renal calculus with IPA>30°,MPCNL and FURS have little difference in stone removal effect,but with IPA≤30°,the FURS calculus removal effect is limited,and the combined application with MPCNL can obtain better treatment effect;Moreover,high BMI,small IPA,long IL,and large calculus diameter are independent risk factors that lead to poor postoperative efficacy of inferior calyx stones.

Key words: infundibulum of the renal pelvis, calculus in the lower renal calyx, curative effect, related factors

[1] 廖黄峻清 张秋红 郭震浪 向松涛. 影像学与人工智能在预测体外冲击波碎石疗效中的运用[J]. 临床外科杂志, 2022, 30(2): 105-108.
[2] 陈家财 曾宾华 李金雨 罗辉 林山. 腹腔镜下肾动脉阻断肾部分切除术治疗cT1期肾癌的疗效及对肾功能的影响[J]. 临床外科杂志, 2022, 30(2): 121-124.
[3] 佘明杰 徐永建 张佩君 付强 卢伟 刘小虎. 早期和延期腹腔镜胆囊切除术治疗胆囊结石性胰腺炎疗效分析[J]. 临床外科杂志, 2022, 30(2): 186-188.
[4] 芦斌 梁立卓. 人工股骨头置换术治疗老年股骨粗隆间骨折的手术学指标及骨密度、髋关节功能变化观察[J]. 临床外科杂志, 2022, 30(2): 193-195.
[5] 李小川 黄春明 罗绍坚 范武 董智晖 蓝根 卢明南 林强祯 陆军海韦健 黎欲强 黄冀. 颈前路Hybrid术式治疗跳跃节段颈椎病的临床观察[J]. 临床外科杂志, 2022, 30(1): 65-69.
[6] 辛国军 王建承 翁原驰 张俊. 全胰腺切除术9例临床疗效分析[J]. 临床外科杂志, 2021, 29(7): 619-621.
[7] 顾越雷 郭德凯 李镇伽 江雨波 刘蕾. 腹腔镜胆总管切开探查取石+腹腔镜胆囊切除术与经内镜逆行胰胆管造影/内镜下括约肌切开取石+腹腔镜胆囊切除术治疗结石性急性梗阻性化脓性胆管炎的疗效比较[J]. 临床外科杂志, 2021, 29(7): 622-625.
[8] 李鑫, 顾绍栋, 罗洪等. 治疗性血管新生在尿道下裂手术中的应用分析[J]. 临床外科杂志, 2021, 29(6): 514-516.
[9] 李干斌 韩加刚 王振军 魏广辉 渠浩 翟志伟 易秉强 马华崇 杨勇王建良 李竹林. 新辅助放化疗治疗局部进展期直肠癌的远期疗效及预后因素分析[J]. 临床外科杂志, 2021, 29(5): 422-427.
[10] 王全晖, 拜云虎, 袁守信. 双镜联合治疗胆总管结石术中不同一期缝合方式对病人的疗效及预后的影响评估[J]. 临床外科杂志, 2021, 29(2): 181-183.
[11] 聂金琳, 张浩然, 陈长顺. Castleman病三例[J]. 临床外科杂志, 2021, 29(2): 199-200.
[12] 黄志强 李虎 马楠 孔德志. 输尿管软镜及微造瘘经皮肾镜碎石治疗肾下盏结石的临床疗效及对血清降钙素原、C反应蛋白、白细胞介素-6水平的影响[J]. 临床外科杂志, 2021, 29(11): 1068-1070.
[13] 黄伟 李荣伟 郭凤 傅楚华 冯波 孙立鹏 柳亚岐 徐东宝. 精准定位下神经内镜治疗脑室出血的疗效及安全性分析[J]. 临床外科杂志, 2021, 29(10): 930-932.
[14] 夏漫辉 冷云华 季灿平 丁学武 陈佳杰. 胸腔镜食管癌切除联合左侧颈部吻合治疗食管癌的疗效及其对呼吸功能的影响[J]. 临床外科杂志, 2020, 28(8): 760-763.
[15] 杨义超 常媛媛 陈玉杰 杨亮 韩静 熊英. 聚桂醇硬化与外科手术治疗痔病的短期疗效对比分析[J]. 临床外科杂志, 2020, 28(8): 778-780.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 宫念樵. 器官捐献供肾质量评估[J]. 临床外科杂志, 2016, 24(10): 729 .
[2] 黄洪锋. 关注公民逝世后器官捐献肾移植受体围手术期感染的预防与处理[J]. 临床外科杂志, 2016, 24(10): 732 .
[3] 邱江. 心脏死亡捐献供肾移植免疫抑制方案的选择[J]. 临床外科杂志, 2016, 24(10): 735 .
[4] 林俊. 原发性中枢神经系统恶性肿瘤供者在器官移植中的应用[J]. 临床外科杂志, 2016, 24(10): 737 .
[5] 胡善彪;余少杰;彭龙开. 婴幼儿供肾移植[J]. 临床外科杂志, 2016, 24(10): 741 .
[6] 昌盛. 中国心脏死亡捐献供肾器官的维护[J]. 临床外科杂志, 2016, 24(10): 744 .
[7] 杨华;李新长;龙成美;等. 公民逝世后器官捐献供肾移植临床分析[J]. 临床外科杂志, 2016, 24(10): 747 .
[8] 石宇;刘学刚 . 冠状动脉旁路移植术后短期内应用强化他汀对患者出血风险的研究[J]. 临床外科杂志, 2016, 24(10): 750 .
[9] 陈忠;王耀东;田毅峰;等. 肝胆管结石病规范化治疗的临床分析[J]. 临床外科杂志, 2016, 24(10): 753 .
[10] 齐卫鹏;王剑明;刘颜;等. 术前应用靛氰绿检测联合三维重建成像评估肝门部胆管癌肝脏储备功能[J]. 临床外科杂志, 2016, 24(10): 756 .